A5-A dual-target antiviral compound that rewrites the rules of influenza therapy
1Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Acta Pharmaceutica Sinica. B
|September 2, 2025
Abstract
No abstract available in PubMed .


